Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | PPARG | P37231 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | PPARA | Q07869 | 7/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL825631 | 1.00 | GPR84 (0.45) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL2235152 | 1.00 | GPR84 (0.45) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL2235149 | 1.00 | GPR84 (0.45) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL28530660 | 1.00 | GPR84 (0.45) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL28530662 | 1.00 | GPR84 (0.45) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL29031151 | 0.98 | GPR84 (0.44) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL8960944 | 0.92 | FFAR4 (0.39) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL9121167 | 0.92 | FFAR4 (0.39) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL2591633 | 0.91 | PPARG (0.54) | PPARGPPARDPPARATSHRPTPN1 | |
| SCHEMBL2591639 | 0.91 | PPARG (0.54) | PPARGPPARDPPARATSHRPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113143903-B | Application of chlorogenic acid-containing pharmaceutical composition in preparation of antiviral drugs | 天津中医药大学 | 2023-01-17 | — | — | CN | disclosed |
| CN-114901071-A | Peripherally acting compositions containing Cannabidiol (CBD) and their use for enhancing female sexual function or treating female sexual disorders | 维拉生物科技有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-11135287-B2 | Method for preparing composition comprising a cationic oil-in-water emulsion | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2021-10-05 | — | — | US | disclosed |
| US-11026890-B2 | Oil-in-water emulsions that contain nucleic acids | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2021-06-08 | — | — | US | disclosed |
| US-20190321268-A1 | APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS | PPP&C INC. DBA ROBIN MCGRAW REVELATION | 2019-10-24 | — | — | US | disclosed |
| US-20190321269-A1 | APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS | PPP&C INC DBA ROBIN MCGRAW REVELATION (US) | 2019-10-24 | — | — | US | disclosed |
| US-20190321270-A1 | APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS | PPP&C INC. DBA ROBIN MCGRAW REVELATION | 2019-10-24 | — | — | US | disclosed |
| US-20190314251-A1 | APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS | PPP&C INC DBA ROBIN MCGRAW REVELATION (US) | 2019-10-17 | — | — | US | disclosed |
| US-20190262448-A1 | Cationic Oil-In-Water Emulsions | GLAXOSMITHKLINE BIOLOGICALS, SA (BE) | 2019-08-29 | — | — | US | disclosed |
| US-20190254968-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2019-08-22 | — | — | US | disclosed |
| US-9655845-B2 | Oil-in-water emulsions that contain nucleic acids | GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) | 2017-05-23 | — | — | US | disclosed |
| US-20160256541-A1 | Cationic Oil-In-Water Emulsions | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2016-09-08 | — | — | US | disclosed |
| US-9295646-B2 | Cationic oil-in-water emulsions | NOVARTIS AG (CH) | 2016-03-29 | — | — | US | disclosed |
| US-20140212498-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2014-07-31 | — | — | US | disclosed |
| EP-2729125-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | Novartis AG (CH) | 2014-05-14 | — | — | EP | disclosed |
| EP-2590625-A2 | CATIONIC OIL-IN-WATER EMULSIONS | Novartis AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| WO-2013006834-A1 | OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS | NOVARTIS AG (CH) | 2013-01-10 | — | — | WO | disclosed |
| US-20120156251-A1 | CATIONIC OIL-IN-WATER EMULSIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2012-06-21 | — | — | US | disclosed |
| WO-2012006380-A2 | CATIONIC OIL-IN-WATER EMULSIONS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |
| US-5776486-A | DEPRESSURIZATION | APHIOS CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |